Wolf H - Search Results

1

Prophylaxis of deep vein thrombosis in high risk patients undergoing total hip replacement with low molecular weight heparin plus dihydroergotamine.

Haas S, Stemberger A, Fritsche HM, Welzel D, Wolf H, Lechner F, Blümel G. Haas S, et al. Among authors: wolf h. Arzneimittelforschung. 1987 Jul;37(7):839-43. Arzneimittelforschung. 1987. PMID: 2823840 Clinical Trial.

2

Effect of low molecular weight heparin on coagulation parameters and bleeding time in healthy volunteers.

Warning A, Nies D, Wolf H, Welzel D. Warning A, et al. Among authors: wolf h. Arzneimittelforschung. 1987 Jul;37(7):847-9. Arzneimittelforschung. 1987. PMID: 2823841 Clinical Trial.

3

Antithrombotic defense during the postoperative period. Clinical documentation of low molecular weight heparin.

Welzel D, Wolf H, Koppenhagen K. Welzel D, et al. Among authors: wolf h. Arzneimittelforschung. 1988 Jan;38(1):120-3. Arzneimittelforschung. 1988. PMID: 2835055 Clinical Trial.

4

[Evaluation of the prevention of perioperative thromboembolism with low molecular weight heparin and dihydroergotamine. A study of the incidence of lethal pulmonary embolisms and undesired symptoms, especially the risk of vasospasm and myocardial infarction].

Wolf H, Welzel D, Kaiser H, Majer M, Schäfer D, Husfeldt KJ, Voigt J, Sunder-Plassmann L. Wolf H, et al. Arzneimittelforschung. 1988 Oct;38(10):1516-9. Arzneimittelforschung. 1988. PMID: 3196393 German.

5

Comparison of 3,000 IU aXa of the low molecular weight heparin certoparin with 5,000 IU aXa in prevention of deep vein thrombosis after total hip replacement. German Thrombosis Study Group.

Adolf J, Fritsche HM, Haas S, Hennig FF, Horbach T, Kastl S, Koppenhagen K, Michaelis HC, Rhamanzadeh R, Summa W, Wagner W, Weber U, Wolf H. Adolf J, et al. Among authors: wolf h. Int Angiol. 1999 Jun;18(2):122-6. Int Angiol. 1999. PMID: 10424367 Clinical Trial.

6

Low molecular weight heparin and prevention of postoperative thrombosis in abdominal surgery.

Koppenhagen K, Adolf J, Matthes M, Tröster E, Roder JD, Hass S, Fritsche HM, Wolf H. Koppenhagen K, et al. Among authors: wolf h. Thromb Haemost. 1992 Jun 1;67(6):627-30. Thromb Haemost. 1992. PMID: 1324534 Clinical Trial.

7

Comparison of the efficacy and safety of Sandoz low molecular weight heparin and unfractionated heparin: interim analysis of a multicenter trial.

Wolf H, Encke A, Haas S, Welzel D. Wolf H, et al. Semin Thromb Hemost. 1991 Oct;17(4):343-6. doi: 10.1055/s-2007-1002632. Semin Thromb Hemost. 1991. PMID: 1666454 Clinical Trial. No abstract available.

8

Effect of heparin and dihydroergotamine on platelet adenosine-3',5'-cyclic monophosphate.

Zahavi M, Welzel D, Wolf H, Honey A, Kakkar VV. Zahavi M, et al. Among authors: wolf h. Arzneimittelforschung. 1987 Jun;37(6):669-74. Arzneimittelforschung. 1987. PMID: 2822055

9

Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis.

Sasahara AA, Koppenhagen K, Häring R, Welzel D, Wolf H. Sasahara AA, et al. Among authors: wolf h. Br J Surg. 1986 Sep;73(9):697-700. doi: 10.1002/bjs.1800730906. Br J Surg. 1986. PMID: 3530367 Clinical Trial.

10

Prevention of deep vein thrombosis in neurosurgical patients: a prospective double-blind comparison of two prophylactic regimen.

Voth D, Schwarz M, Hahn K, Dei-Anang K, al Butmeh S, Wolf H. Voth D, et al. Among authors: wolf h. Neurosurg Rev. 1992;15(4):289-94. doi: 10.1007/BF00257808. Neurosurg Rev. 1992. PMID: 1336131 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,209 results

Search Page

Filters